Vivo Capital, LLC has filed its 13F form on November 13, 2024 for Q3 2024 where it was disclosed a total value porftolio of $683 Million distributed in 43 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Geron Corp with a value of $124M, Harmony Biosciences Holdings, Inc. with a value of $104M, Verona Pharma PLC with a value of $102M, Terns Pharmaceuticals, Inc. with a value of $57.5M, and Dyne Therapeutics, Inc. with a value of $40M.

Examining the 13F form we can see an increase of $6.31M in the current position value, from $677M to 683M.

Vivo Capital, LLC is based out at Palo Alto, CA

Below you can find more details about Vivo Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $683 Million
Healthcare: $683 Million

Stock Holdings Table Market Cap. of $10 Billions to $200 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 43
  • Current Value $683 Million
  • Prior Value $677 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 13, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 6 stocks
  • Additional Purchases 3 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 8 stocks
Track This Portfolio

Track Vivo Capital, LLC Portfolio

Follow Vivo Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vivo Capital, LLC with notifications on news.